Skip to main content

Packaging, labelling and marketing of pharmaceuticals has evolved rapidly in India, with concerns about ‘deceptive similarity’ at the helm. Our Pharma Dossier (Vol. 1) discusses trade mark jurisprudence in light of the primary factor – the consumer.

Whereas differentiation on the basis of a name may have become more constrictive, creative use of unconventional marks and branding exercises by pharmaceutical companies has aided the creation of unique identities. Useful, with the rate e-pharmacies are disrupting traditional distribution models.

 

To read more, contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
Mar 10, 2026

‘First published on BW Legal World’ By: Safir Anand, Mudit Kaushik and Sehr Anand India has strong design talent, ranging from local craftspeople to

Not Just Made in India – Designed in India The Budget’s Most Strategic Move
News & Updates, Thought Leadership
Mar 10, 2026

‘First published on BW Legal World’ By: Pravin Anand and Dr. Ajai Garg The Summit underscored a broader reality: artificial intelligence is no longer

India AI Impact Summit 2026: Law, Leadership, and India’s AI Moment
Thought Leadership
Feb 13, 2026

‘First published on Enterprise IT World’ By: Subroto Kumar Panda How the 2026 IT Rule Amendments Protect You in the Age of AI In an era where seeing

The Digital Armor – 2026
Thought Leadership
Feb 11, 2026

Authors: Safir Anand, Mudit Kaushik and Sehr Anand The establishment of a new National Institute of Design (NID-East) in India’s eastern region,

Can New NID-East Ignite India’s Design Revolution?